Perioperative management to reduce cardiovascular events

Circulation

Volumn 133, Issue 11, 2016, Pages 1125-1130

  Smilowitz, Nathaniel R ^a   Berger, Jeffrey S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTILIPEMIC AGENT; APIXABAN; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; DABIGATRAN; EDOXABAN; FONDAPARINUX; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL SUCCINATE; RIVAROXABAN; THROMBIN INHIBITOR; WARFARIN; ANTICOAGULANT AGENT; TICLOPIDINE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; STRESS ECHOCARDIOGRAPHY; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANESTHESIA; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COMPLICATION; CONTRAINDICATIONS; CORONARY DISEASE; DISEASE PREDISPOSITION; KNEE REPLACEMENT; PHYSIOLOGICAL STRESS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREMEDICATION; PROCEDURES; RISK FACTOR; SURGERY; THROMBOPHILIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANESTHESIA; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; CORONARY DISEASE; DISEASE SUSCEPTIBILITY; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; MALE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PREANESTHETIC MEDICATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; STRESS, PHYSIOLOGICAL; SURGICAL PROCEDURES, OPERATIVE; THROMBOPHILIA; TICLOPIDINE;

EID: 84961789667     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017787     Document Type: Article

References (20)

1. Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study I, Devereaux PJ, Chan MT, Alonso-Coello P, Walsh M, Berwanger O, Villar JC, Wang CY, Garutti RI, Jacka MJ, Sigamani A, Srinathan S, Biccard BM, Chow CK, Abraham V, Tiboni M, Pettit S, Szczeklik W, lurati Buse G, Botto F, Guyatt G, Heels-Ansdell D, Sessler DI, Thorlund K, Garg AX, Mrkobrada M, Thomas S, Rodseth RN, Pearse RM, Thabane l, McQueen MJ, VanHelder T, Bhandari M, Bosch J, Kurz A, Polanczyk C, Malaga G, Nagele P, le Manach Y, leuwer M, Yusuf S. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295-2304
2. Devereaux PJ, Yang H, Yusuf S, Guyatt G, leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan l, Pogue J, Pais P, liu l, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P; POISE Study Group. Effects of extended-release metoprolol suc-cinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839-1847. doi: 10.1016/S0140-6736(08)60601-7.
3. Devereaux PJ, Mrkobrada M, Sessler DI, leslie K, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow Jl, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, lurati Buse G, Xavier D, Chan MT, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin l, le Manach Y, Gao P, Pogue J, Whitlock R, lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S; POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494-1503. doi: 10.1056/NEJMoa1401105.
4. Oberweis BS, Smilowitz NR, Nukala S, Rosenberg A, Xu J, Stuchin S, Iorio R, Errico T, Radford MJ, Berger JS. Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery. Am J Cardiol. 2015;115:1643-1648. doi: 10.1016/j.amjcard.2015.03.003.
5. Schneider GS, Rockman CB, Berger JS. Platelet activation increases in patients undergoing vascular surgery. Thromb Res. 2014;134:952-956. doi: 10.1016/j. thromres.2014.08.009.
6. Fleisher lA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN; American College of Cardiology; American Heart Association. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing non-cardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;130:e278-e333. doi: 10.1161/CIR.0000000000000106.
7. Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092-2099. doi: 10.1001/jama.291.17.2092.
8. Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, Verhagen HJ, Khan NA, Dunkelgrun M, Bax JJ, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980-989. doi: 10.1056/NEJMoa0808207.
9. Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F. Meta-analysis of the effects of statins on perioperative outcomes in vascular and endo-vascular surgery. J Vasc Surg. 2015;61:519-532.e1. doi: 10.1016/j.jvs.2014.10.021.
10. Sanders RD, Nicholson A, lewis SR, Smith AF, Alderson P. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev. 2013;7:CD009971. doi: 10.1002/14651858.CD009971.pub2.
11. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349-361. doi: 10.1056/NEJMoa041895.
12. Flu WJ, van Kuijk JP, Chonchol M, Winkel TA, Verhagen HJ, Bax JJ, Poldermans D. Timing of pre-operative Beta-blocker treatment in vascular surgery patients: infu-ence on post-operative outcome. J Am Coll Cardiol. 2010;56:1922-1929. doi: 10.1016/j. jacc.2010.05.056.
13. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel Tl, Pauker SG, Colwell CW Jr; American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e278S-e325S. doi: 10.1378/chest.11-2404.
14. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295-1302.
15. Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea Ml, Vargas-Castrillón E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ. 2012;344:e3675.
16. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu l, Ellis N, Reda DJ, Henderson WG. Coronary-artery revas-cularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-2804. doi: 10.1056/NEJMoa041905.
17. Wilson SH, Fasseas P, Orford Jl, lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42:234-240.
18. Hawn MT, Graham lA, Richman JS, Itani KM, Henderson WG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310:1462-1472. doi: 10.1001/jama.2013.278787.
19. Wijeysundera DN, Wijeysundera HC, Yun l, Wasowicz M, Beattie WS, Velianou Jl, Ko DT. Risk of elective major non-cardiac surgery after coronary stent insertion: a population-based study. Circulation. 2012;126:1355-1362. doi: 10.1161/CIRCUlATIONAHA.112.102715.
20. van Kuijk JP, Flu WJ, Schouten O, Hoeks SE, Schenkeveld l, de Jaegere P P, Bax JJ, van Domburg RT, Serruys PW, Poldermans D. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol. 2009;104:1229-1234. doi: 10.1016/j. amjcard.2009.06.038.